Discover the full record of transactions filed by Weisblum Eric, Chief Executive Officer. Officer active across 1 companies, notably Silo Pharma, Inc.. Aggregated, 7 filings have been logged. Total volume traded: €3k. The latest transaction was filed on 17 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Eric Weisblum serves as the Chief Executive Officer, Chief Financial Officer, and President of Silo Pharma, Inc. He oversees the company's operations and is responsible for financial management. His leadership is essential for the success of the organization.